학술논문

Selected E2F2 Polymorphisms in Oral and Oropharyngeal Squamous Cell Carcinoma.
Document Type
Article
Source
BioMed Research International. 3/30/2021, p1-7. 7p.
Subject
*MOUTH tumors
*DNA
*CARCINOGENESIS
*OROPHARYNGEAL cancer
*HEAD & neck cancer
*GENETIC polymorphisms
*CELL physiology
*TUMOR classification
*CANCER patients
*GENOTYPES
*TRANSCRIPTION factors
*SQUAMOUS cell carcinoma
*TUMOR grading
Language
ISSN
2314-6133
Abstract
Oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) are subgroups of head and neck squamous cell carcinoma. E2F Transcription Factor 2 (E2F2) could contribute to cancer development, because it plays a critical role in many cellular processes, including the cell cycle, proliferation, differentiation, DNA damage response, and cell death. In the current study, we assessed the associations of five E2F2 polymorphisms (rs6667575, rs3218121, rs3218211, rs3218148, and rs3218203) with OSCC and OPSCC and influence on the TNM staging and grading. This is the first such survey to concern the European population. The study included 94 primary tumour samples following surgical resection from patients, whereas the control group consisted of 99 healthy individuals. We tried a matching of cases and controls for age and sample size. DNA samples were genotyped by employing the 5 ′ nuclease assay for allelic discrimination. Our results suggested that the most significant difference between the control group and the cancer group was the A/G heterozygote for rs3218121. Samples containing this genotype were mostly found in the control group. In our samples, rs6667575, rs3218121, rs3218211, and rs3218148 polymorphisms may affect the course of OSCC and OPSCC, while rs3218203 was not associated with OSCC and OPSCC. However, further studies are warranted to confirm our findings. [ABSTRACT FROM AUTHOR]